Abstract
To assess the impact of low-concentration contrast medium on vascular enhancement, image quality, and radiation dose of coronary computed tomography (CT) angiography (CCTA) by using prospectively electrocardiography (ECG)-triggered high-pitch spiral acquisition with low tube voltage in combination with iterative reconstruction. One hundred patients (body mass index≤25kg/m(2), heart rate≤65 beats per minute) were prospectively randomized to two groups, with 50 patients each, which were differed by contrast medium. All patients underwent prospectively ECG-triggered high-pitch spiral acquisition CCTA (2×128×0.6mm, 300mAs). Group A patients received iopromide 370 (370mgI/mL), were scanned using 100 kVp, and reconstructed with filtered back projection. Group B patients received Iodixanol 270 (270mg I/mL), were scanned using low tube voltage of 80 kVp, and reconstructed with iterative reconstruction techniques (IRT). CT attenuation was measured in coronary artery and other anatomic regions. Image quality score, noise, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiation dose were calculated and compared. The iodixanol 270 group showed no significant difference in image quality score (1.61±0.69 vs 1.57±0.66; P>.05), CT attenuation (P>.05), noise (P>.05), SNR (47.89±14.03 vs 44.37±12.79; P>.05), and CNR (42.38±12.67 vs 38.13±11.38; P>.05) in comparison to the iopromide 370 group but at a significantly lower radiation dose (0.26±0.05 vs 0.57±0.10; P<.001), which reflects dose saving of 54.4%. Combining IRT with high-pitch spiral acquisition mode and low-tube-voltage technique, a low-concentration contrast medium of 270 mg I/mL can still maintain the contrast enhancement in coronary arteries without impairing image quality and significantly lower the radiation dose.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
